Author: BusinessWire

ANN ARBOR, Mich.–(BUSINESS WIRE)–Millendo
Therapeutics, Inc. (Nasdaq: MLND), a clinical-stage
biopharmaceutical company developing novel treatments for orphan
endocrine diseases, announced today that its clinical candidates,
…

— Edasalonexent Phase 3 PolarisDMD Trial Globally Enrolling Boys
with Duchenne Muscular Dystrophy —

CAMBRIDGE, Mass.–(BUSINESS WIRE)–Catabasis
Pharmaceuticals, Inc. (NASDAQ:CATB), a clinical-stage
biopharmaceutica…

– Oral Hereditary Angioedema (HAE) Candidate KVD900 Phase 2 Trial
Progressing –

– Intravitreal Diabetic Macular Edema (DME) Candidate KVD001 Phase
2 Trial Completion Expected H2 2019 –

– Oral Plasma …

— $2 million in seed funding raised to advance development —

— Kevin Kalish joins EnClear as Vice-President of Research and
Development —

CAMBRIDGE, Mass.–(BUSINESS WIRE)–EnClear
Therapies, a biotechnol…

DUBLIN–(BUSINESS WIRE)–The “Betaseron
– Drug Insight, 2019” report has been added to ResearchAndMarkets.com’s
offering.

Betaseron Drug Insight, 2019 highlights the drug
marketed details and the Global API Manufact…

Globally recognized leader in antiviral drug discovery and development

DURHAM, N.C.–(BUSINESS WIRE)–lt;a href="https://twitter.com/hashtag/celltherapy?src=hash" target="_blank"gt;#celltherapylt;/agt;–Precision BioSc…

European Approval Based on KEYNOTE-407 Study Results Demonstrating
Significant Improvement in Overall Survival with KEYTRUDA in Combination
with Chemotherapy Compared to Chemotherapy Alone

KEYTRUDA is First Anti-PD-…

TOKYO–(BUSINESS WIRE)–lt;a href="https://twitter.com/hashtag/OM?src=hash" target="_blank"gt;#OMlt;/agt;–Solasia Pharma K.K. (TOKYO:4597, Headquarters:Tokyo, Japan, President &
CEO:Yoshihiro Arai, hereinafter “Solasia”)…

DUBLIN–(BUSINESS WIRE)–The “Methycobal
Tablets – Drug Insight, 2019” report has been added to ResearchAndMarkets.com’s
offering.

Methycobal Tablets Drug Insight, 2019 highlights the
drug marketed details and the G…

DUBLIN–(BUSINESS WIRE)–The “Sevikar
– Drug Insight, 2019” report has been added to ResearchAndMarkets.com’s
offering.

Sevikar Drug Insight, 2019 highlights the drug marketed
details and the Global API Manufacturer…